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Summary 
Fas-mediated apoptosis is essential for activation-induced cell death of oe/B T cells, but it is not 
clear what role, if any, it plays in regulating other components of the immune system. To study 
the role of Fas in 3~/~ T cell development, Fas-deficient lpr mice were bred with T cell receptor 
oe gene-ablated (TCR-o~ -/-)  mice to generate mice deficient in one or both genes. The TCK- 
ce -/-,  Ipr/lpr mice had a nearly 10-fold increase in total lymph node cell (LNC) number compared 
with Fas-intact TCR-c~-/-  mice, because of expansion of TCK-3#/~ + and TCKq3 + cells. In 
Fas-intact TCK-c~ -/-  mice, approximately one third of the LNCs expressed TCR-'y/& These 
were evenly divided between the CD4-,  CD8-c, + and the CD4-,  CD8-  subsets,  and rarely 
expressed the B220 epitope of CD45. In contrast, in TCR-oe-/-, lpr/Ipr mice, TCR-'y//~ + cells 
comprised half of the LNCs and were primarily CD4-,  CD8-,  and B220 +.  Moreover,  Fas 
deficiency in TCK-cx -/-  mice caused a preferential expansion of qr/~ T cells expressing variable 
region genes characteristic  of intestinal intraepithelial lymphocytes. These results demonstrate 
a role for Fas in regulating the 3r//) T cell contribution to peripheral lymph nodes. This mechanism 
may be most important in limiting the access of activated intestinal intraepithelial lymphocytes 
to the peripheral lymphoid system. 
F  as is a cell surface receptor,  signaling through which in- 
duces apoptosis in the Fas-bearing cell (1-3).  In mice the 
gene is expressed at its highest level in the thymus, with lower 
levels detected in liver, heart, and ovary (4). It has also been 
reported on mature T  cells with an activated  or memory 
phenotype (5,  6)  and has been shown to be essential  in 
activation-induced cell death (AICD) t of ce/13 T  cells (7). 
Much of what is known about Fas has come from studies 
of a naturally occurring Fas-deficient mutant, the Ipr mouse. 
Watanabe-Fukunaga et al. (8), and subsequently others (9), 
have shown that.~s is disrupted in Ipr mice by the insertion 
of an early transposable  element (Etn) in the second intron 
of the gene. These mutant mice express little or no Fas on 
their thymocytes or mature T  cells (10, 11) and exhibit a 
number of abnormalities of T cell development. The most 
obvious effects of this mutation are T cell autoimmunity (12), 
1  Abbreviations used in this paper: AICD, activation-induced cell death; DN, 
double  negative;  Etn,  early  transposable  dement;  IHL,  intrahepatic 
lymphocytes; iIEL, intestinal intraepithdial  lymphocytes; LNC, LN cells; 
Neo  R, neoresistance gene; SP, single positive; TCR-a-/-, TCR-c~ gene 
ablated; Tg TCR, transgenic TCK. 
and the massive accumulation of polydonal c~/13 T cells, which 
express a reduced level of TCR (13) and express neither CD4 
nor CD8 (o~/3 double-negative [DN] T  cells) (14). These 
cells express the B220 epitope of CD45 (14), which is nor- 
mally found only on B cells. 
While the molecular basis of the/pr defect is now known 
and the phenotype of the accumulating oL/3 DN T cells in 
these mice has been well described, the mechanism by which 
Fas deficiency  leads to this accumulation remains unclear. Since 
Fas is expressed at high levels in the thymus (11), it has been 
suggested that the lack of Fas-mediated apoptosis during 
thymic repertoire selection gives rise to the abnormalities found 
in lpr mice (8, 15-17). However, recent experiments crossing 
the lpr mutation with a CD8-restricted transgenic TCK (Tg 
TCK) specific for the male antigen H-Y presented by H-2D  b 
have shown by examining the LN T cells that positive and 
negative selection in the thymus was mostly intact (18-20). 
Even expression of a Tg TCR43 chain alone, where endoge- 
nous TCR-ce can pair with the transgene to form receptors 
of many specificities, did not develop DN T cell lymphade- 
nopathy (21). More recently, Singer and Abbas have used an 
lpr mouse with a CD4-restricted Tg TCK specific for a pep- 
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duced by exogenous peptide antigen was intact in the thymus 
of these mice (7). Thus,  if the ol/B DN T  cells in lpr mice 
arise in the thymus, they must come from an unselected pool 
of double-positive thymocytes that have failed to make a com- 
plete TCR complex. 
An alternative possibility is that the phenotypic similarity 
between Ipr ol/~ DN T  cells and immature  thymocytes is 
misleading,  and that  these cells develop instead from acti- 
vated peripheral single-positive (SP) T  cells. When a T  cell 
is exposed to its cognate antigen,  it becomes activated and 
clonally expands, leading to an effector response. After this 
response, most of the responder cells are removed from the 
system by AICD  (22).  Fas-mediated apoptosis is probably 
essential for AICD of T cells. Several groups have shown that 
in lpr mice it is more difficult to induce peripheral tolerance 
to a superantigen (23-25) and the lpr mice do not maintain 
neonatal tolerance (23). More recently, Singer and Abbas used 
pigeon cytochrome C Tg TCR/pr mice to show that AICD 
was defective in Fas-deficient mice (7). These mice failed to 
delete their peripheral T  cells in response to a large dose of 
antigenic peptide in vivo, whereas Fas-intact Tg TCR mice 
deleted these cells. Thus, in the absence of Fas, both periph- 
eral  tolerance and AICD  were severely impaired. 
Expression of the B220 epitope of CD45 by T  cells may 
be a hallmark  of AICD,  and we have shown recently that 
the liver is an important site for its expression on T cells be- 
fore deletion (26).  Using mice with a Tg TCR specific for 
a peptide of SV40 large T  antigen  in the context of H-2  k, 
we have shown that exposure of T cells to their cognate an- 
tigen in vivo induced expression of a variety of activation 
markers on the responding cells, including B220. These acti- 
vated cells  trafficked to the liver,  down-regulated  their ex- 
pression of CD8,  and underwent apoptosis. These findings 
suggest that the liver is a major site for elimination of T cells 
in AICD. 
In  examination  of intrahepatic  lymphocytes  (IHLs)  of 
normal,  unmanipulated  mice, we found a population  of T 
cells that  resembled the ol/3 DN T  cells of lpr mice (27). 
These cells expressed B220 but neither coreceptor and had 
a reduced level of TCR-oJ3  on their  surface.  The B220 + 
but not the B220- population of IHLs contained cells that 
were proliferating and cells undergoing apoptosis. In lpr mice 
these cells were detectable in the liver before they could be 
found in the peripheral LNs (28). Taken together, these data 
suggest the hypothesis that B220 expression in T  cells is a 
marker of incipient Fas-mediated cell death and that a failure 
of Fas-mediated apoptosis in IHLs in lpr mice leads to their 
accumulation  and eventual export  into  the LNs as B220 + 
c~/3 DN T  cells. 
While the role of Fas and AICD in controlling peripheral 
ol/3 T cell number is thus becoming clearer, little is known 
about the regulation of 3'/6 T cell number. In fact, very little 
is known about the antigen(s)  that  normally  activate 3~/8 
T cells,  the normal role of "y/8 T cell effector responses, or 
the capacity of 3'/6 T cells to be regulated by activation and 
apoptosis. Because of their prevalence in the skin and mucosal 
surfaces, it has been proposed that they may act as a first line 
of defense against invading pathogens,  though,  again,  how 
they might  be regulated is uncertain. 
The ol/3 T cells may play a role in regulating y/6 T cells, 
at  least  in  the  LN.  Ablation  of TCR-~  gene  expression 
(TCR-o~-/-)  eliminated the normal c~/3 T  cell pool and 
all of its effector responses and allowed for an increase in the 
number of "y/6 T  cells developing in peripheral  LNs com- 
pared with mice with wild-type TCR-ot genes (TCR-oe in- 
tact) (29, 30). This expansion of'y/6 T cells in TCR-o~ -/- 
mice has  greatly facilitated the study of this normally rare 
population  of lymphocytes.  To  study  the  role  of Fas  in 
regulating 3'/6 T cells, we bred TCR-ot-/-  mice with lpr 
mice to generate animals deficient in expression of both genes. 
We examined the LN cells (LNCs) of these mice and com- 
pared them to those of their littermates with wild-type ex- 
pression of one or both genes.  With  this  system we were 
able to examine the role of Fas in regulating peripheral 3'/6 
T  cells and at the same time to test the hypothesis that un- 
selected DP thymocytes give rise to or~3 DN T cells in lpr mice. 
Materials and Methods 
Mice.  TCR-~-/-  mice of the 129 strain have been described 
(29). MRL-lpr/Ipr mice were purchased from The Jackson Labora- 
tory (Bar Harbor,  ME) and bred with the TCR-~-/-  mice in 
a specific  pathogen-free environment in the Immunobiology Mouse 
Unit  (Yale University  School of Medicine,  New Haven,  CT). 
Progeny of this mating were interbred to generate F2 mice, which 
were used at 16 wk of age. 
PCR Typing of TCR-ol and fas/Ipr Gene Loci.  Tail  DNA from 
F2 mice were resuspended in 100/A of Tris-EDTA, and this sus- 
pension was diluted 1:20 in HzO to make tail template DNA. The 
following primers were used for PCR: TCRCAF1, TCCAGAACC- 
CAGAACCTGCTGTG;  TCRCAR1, CCTGAACTGGGGTAG- 
GTGGC~; NEOMS1, CCT~oCGCAC~TGTGCTCGACGTTG; 
FASI2FX,  ACAGCATAGATTCCATTTGCTGCT;  FASI2REV, 
TGAGTAATGGGCTCAGTGCAGCA; and FASZ8XTR,  CAA- 
ATTTTATTGTTGCGACACCA (modified from Adachi et al. [31]). 
PCR reactions contained 5 #1 tail DNA template, 20 mM Tris- 
HCL (pH 8.4), 50 mM KC1, 2.5 mM MgC12, 0.2 mM each of 
dATE  dCTP,  dGTP,  and dTTP (Pharmacia Biotech,  Inc.,  Pis- 
caraway, NJ), 100 ng of each of four primers, and 1 U Taq Poly- 
merase (Gibco BRL, Gaithersburg,  MD) in a final volume of 50 
/A, and were run for 30 cycles. Each cycle  consisted of 45 s at 94~ 
I rain at 61.5~  and I rain at 72~  25/zl of each PCR reaction 
was electrophoresed through a 1.2% agarose gel and visualized by 
ethidium bromide staining under UV light.  Wild-type,  Ipr, and 
heterozygous mice were typed in two separate reactions. The for- 
ward primer (FASI2FX), complementary to the second intron  of 
J~s, 5' of the Etn insertion  on Ipr mice, paired with FASI2REV, 
which also primed from within the second intron,  3' to the Etn 
insertion, to give a product of *200 bp in the wild-type reaction. 
No product was seen from Ipr template. The lpr-specific primer 
FASZSXTR reacted with FASI2FX to give a product of'o250 bp. 
Mice were typed for TCR-c~ genotype by PCR, again using two 
reactions. The forward primer TCRCAF1 paired with either the 
knock-out-specific  (neoresistance  gene  [Neo~]-specific) reverse 
primer NEOMS1 (mutant reaction, ,o750 bp) or with TCRCAR1 
(wild-type reaction, ,o300 bp). The wild-type reaction performed 
234  Fas-deficient  TCR-ot Knock-out Mice using TCR-cx -/-  template often gave a band of '-1,800 bp be- 
cause of priming through the Neo  R gene. The two wild-type reac- 
tions and the two mutant reactions were used together to type 
F2 mice for both genes. 
Cells, Antibodies, and FACS  |  Analysis.  F2 mice were killed at 
16 wk of age and 10 peripheral (nonmesenteric) LNs were obtained 
from each mouse. These LN were ground in a tissue homogenizer 
and the LNCs were washed in Bru~s medium with 2% FCS be- 
fore use. Viable cells were counted by nigrosin dye exclusion to 
determine total cell yield from each mouse. 
The following antibodies were used: H57-597-PE (anti-TCR C/3; 
Pharmingen, San Diego, CA) (32), RA3-3A1-FITC (TIB-146, anti- 
B220, kind gift of Kim Bottomly) (33), 3.168-FITC (anti-CDS-o~, 
conjugated and tested in our laboratory) (34), H129-19-Red 613 
(anti-CD4; Gibco BILL)  (35), 53-6.7-Red 613 (anti-CD8-cc, Gibco 
BRL) (36), GL-3-PE  (anti-pan-TCR-7/8; Pharmingen) (37), UC3- 
10A6-PE (anti-TCRV74;  Pharmingen)  (38), 536-PE (anti-V75; 
Pharmingen) (39), Gbl-biotin (anti-V76; kind gift of Leo LeFran- 
cois) (37, 40) followed by streptavidin-PE (Biomeda, Foster City, 
CA) and GL-2-PE (anti-V84; Pharmingen) (37, 40). To study the 
subsets of TCR-B + cells, 1  x  106 LNCs were suspended in 100 
ml BrufPs/FCS and stained with H57-597-PE with either: (a) RA3- 
3A1-FITC plus 53-6.7-Red 613, to study CD8 § cell phenotype; 
(b) RA3-3A1-FITC plus H129-19-Red 613, to study CD4 + cell 
phenotype; (c) RA3-3A1-FITC plus 53-6.7 Red 613 plus H129-19- 
Red 613, to study DN cell  phenotype; or (d) 3.168-HTC plus H129- 
19-Red 613, for CD8 vs CD4 expression. The same staining pat- 
tern was used with GL3-PE to study subsets of 7/8 T cells. Data 
were acquired on a FACScan  |  flow cytometer (Becton Dickinson 
and Co., Cockeysville, MD) using FACScan  |  Research Software 
and analyzed using Lysys  1.7 software (Becton Dickinson and Co.). 
The percentage of cells with each phenotype was determined using 
the TCR-fl + or TCR-7/8 + cell  gate and quadrant regions shown. 
The percentage of cells with each phenotype was multiplied by 
the total cell yield to determine the absolute yield for each subset. 
Results 
Expansion ofT Cells in Fas-deficient TCR-cr -/-  Mice.  To 
generate Fas-deficient mice lacking TCR-c~ expression, we 
bred TCR-ex -/-  mice of strain 129 with MRL-lpr/Ipr mice 
and examined mice of the F2 generation. The TCg-cx and 
)fis genotypes of these mice were determined by PCR anal- 
ysis of tail DNA (Fig. 1). A single forward primer complemen- 
tary to the 5' end of the first exon of the constant region 
of the TCR-ot gene was paired with either a primer from 
the 3' end of that exon (TCR-c~ wild-type reaction) or with 
a  NeoP'-specific  primer  (TCR-ot  mutant  reaction),  iden- 
tifying the genotype of the mice in two reactions. A similar 
strategy was used for the )fis gene, where a single forward 
primer in the second intron was paired with either a reverse 
primer, which is 3' of the Etn insertion in Ipr mice 6fis wild- 
type reaction), or with an Etn-specific reverse primer (Ipr mu- 
tant reaction). The two sets of reactions were used together, 
and the specificity of the typing was checked by FACS  |  anal- 
ysis of Fas, CD4, CD8, and TCR expression in the thymus 
(data not  shown). 
The F2 mice were killed at 16 wk, and the lymphocytes 
from 10 peripheral (nonmesenteric) LNs were pooled. These 
Figure  1.  PCR typing ofF2 (TCR-o~-/-  x MRL-lpr/Ipr)  mice. (A) 
PCR typing strategy. PCR between the primers TCRCAF1 and TCR- 
CAR1 identifies  intact TCR-c~  genes, whereas TCRCAF1 to NEOMS1 
identifies the insert in the TCR Ca knock-outs.  Similarly,  PCR between 
the primers FASI2FX and FASI2REV  identifies  the second  intron of the 
normalfis gene, whereas PCR from FASI2FX to FASZ8XTR  identifies 
the mutant  fas genes containing  the Etn transposon. (B) Typing  reaction. 
The four PCR products unambiguously type  all nine genotypes of F2 
(TCR.-c~  -/-  x MRL-lpr/Ipr)  mice  in two PCR reactions.  The TCR-c~- 
specific product runs above  thefas/Ipr-spedfic product in both reactions. 
All four products were seen using F1 parental DNA, and only the ex- 
pected products were seen when MRL-Ipr/Ipr  or strain 129-TCR-c~-/- 
templates were used alone. 
lymphocytes were stained for TCR-oJfl  or TCR-'y/~ and 
analyzed by FACS  |  The percentage of LNCs expressing ei- 
ther marker was then multiplied by the cell yield for each 
mouse to determine the yield for each cell type. Pooled data 
from 16 litters are shown in Table 1. Heterozygotes for ei- 
ther gene were identical in phenotype of homozygous wild- 
type mice for that  gene;  the data presented here are from 
homozygotes. By 16 wk of age, the Ipr mice with wild-type 
TCR-ol had developed massive lymphadenopathy due to ot/B 
DN T  cell accumulation; '~10% of these mice were mori- 
bund. As previously described (29, 41), ablation of the TCR-ol 
gene led under specific pathogen-free conditions to an in- 
crease in the absolute number of peripheral TCR-7/~ + T 
cells but a decrease in the total number of peripheral lym- 
phocytes because of the dimination of ol/~ T  cells. Massive 
235  Hughes  et al. Table  1.  T  Cell Yield from  LNs 
Genotype  n  LNC  TCR.-B + LNC  TCR-3'/fi + LNC 
c~+/+,  wt/wt  14  57.72  +  17.9  51.66  +_  13.0  0.64  +  0.36 
cz + / +, lpr/Ipr  8  2,680.00  +_  1570  2,220.00  _+  1280  32.00  _+  13.6 
cr  wt/wt  12  9.43  _+  2.77  1.30  _+  0.65  3.14  _+  0.89 
cr  lpr/lpr  9  85.67  +  38.8  7.91  +  2.97  44.60  _+  22.5 
The yield of live lymphocytes from 10 peripheral (nonmesenteric) LNs are shown in millions. Values are mean  _+  SD. Genotype of mice was deter- 
mined by PCR as shown in Fig. 1. The yield of TCR-/~ + cells  was determined by multiplying the total yield of LNCs by the percentage of LNCs 
stained with anti-TCR-/~ mAb. The field of TCR-3,/~ + cells was determined by multiplying the total yield of LNCs by the percentage of LNCs 
stained with anti-TCR-3"//~ mAb. wt, wild type. 
lymphadenopathy was also eliminated in TCR-cz -/-,  lpr/Ipr 
mice. However, absence of Fas in these mice caused a 15-fold 
expansion of TCR--),//~ + T  cells, as well as a 6-fold increase 
in TCR-3 +  cells when  compared with  Fas-intact TCR-cx 
-/-  mice.  The TCR-B +  cells in TCR-c~-/-  mice have 
recently been described (41) and are the subject of ongoing 
study. The increased number of TCR-3,/8 + cells was detect- 
able in TCR-cx +/+,  Ipr/Ipr as well as TCR-c~-/-,  lpr/lpr 
mice,  and  is examined in detail here. 
Fas Deficiency Causes Expansion of TCR-I~ + Cells with Ab- 
normal Phenotypes.  To determine which subsets of TCK-(~ + 
cells were expanding in TCK-cz -/-,  Ipr/lpr mice, we stained 
TCR(~ +/+,  fas: wt/wt 
TCR~ Profile  CD8  1..I0. 
CD4  CD4 
TCRa +/+, Ipr/Ipr 
CD8  CD4  CD4 
TCRI~ Profile 
TCRa -/-, fas: wt/wt 
CD8  CD4  CD4 
TCR~ Profile 
TCR~ -/-, Ipr/Ipr 
CD8  CD4  CD4 
236  Fas-deficient  TCR-~x Knock-out Mice 
Figure 2.  Fas deficiency increases the proportion  of 
B220 + DN cells in TCR-fl  + cells of TCR-oe-/- mice. 
Single  cell suspensions  of  LNCs were stained  in anti-TCR- 
B-PE and either (a) anti-B220-FITC plus anti-CDS-Red 
613; (b) anti-B220-FITC plus anti-CD4-Red 613; or (c) 
anti-CDS-FITC and anti-CD4-Red 613, and analyzed by 
multicolor FACS  |  TCK-/~  + cells  were identified using 
the histogram gate shown to generate these plots. The 
quadrant regions shown were used to calculate the per- 
centage of lymphocytes in each subset. the LNCs of 16-wk-old mice with antibodies TCR-~, CD4, 
CD8, and B220 and analyzed these cells by FACS  |  Repre- 
sentative  FACS  |  plots  are  shown  in  Fig.  2.  Using  the 
TCR-B + gate and quadrant regions shown, we determined 
the percentage in each subset of TCR-/3 + cells. As has been 
described previously by many groups, Fas deficiency led to 
the abnormal development of B220 + TCR-B + DN cells in 
TCK-c~-intact 1~ mice (for review see reference 42). Although 
ablation of TCR-ot gene expression eliminated the normal 
ct//3 T cell pool in Fas-intact TCR-ct -/-  mice, a small popu- 
lation  of TCR-B +  cells  persisted  in  the  peripheral  LNs. 
These cells were CD8 +, DN, or CD4 §  Approximately one 
quarter of the TCR-/8 + cells  in  a Fas-intact TCR-tx-/- 
mouse expressed B220. These cells were mostly DN, with 
a small proportion of CD81~ cells.  In TCR-ot-/-, Ipr/lpr 
mice, the lack of Fas increased the proportion of B220 + DN 
ceils in TCR-/3  + cells, skewing the TCR-~  + population to- 
ward a DN, B220 + phenotype. 
The skewing of TCR-/3 + cells toward a DN, B220 + phe- 
notype in  Fas-deficient  TCR-ot-/-  mice  was  due  to  a 
preferential expansion of the B220 + subsets  in this popula- 
tion (Table 2). The percentage oflymphocytes for each subset 
was determined using the quadrants shown in Fig.  2,  and 
this number was multiplied by the total cell yield for that 
mouse to determine the absolute yield for each subset. Most 
of the TCR-~ + cells in a Fas-intact  TCR-ot-/-  mouse did 
not express B220 and fell within the DN cell quadrant shown 
in Fig. 2, though many in fact expressed CD8 at a low level. 
Absence of Fas in TCR-cr -/-,  Ipr/lpr mice led to an expan- 
sion of most TCR-/3 + cell subsets, but the B220 § subsets, 
especially the DN B220 + pool, increased far more than did 
the B220-  subsets.  Fas deficiency led to a 4-fold expansion 
of the DN B220-  subset,  a  10-fold increase in the CD4 § 
B220 + and the DN B220 + subsets,  and a 5-fold expansion 
of the CD8 + B220 + subset.  This accumulation of B220 + 
TCR-/3 + cells is similar to the preferential accumulation of 
or//3  DN T  cells  seen in TCR-ot-intact lpr mice. 
TCR-T/$ + Cells in Fas-deficient Mice Accumulate and Ac- 
quire an Abnormal Phenotype.  Since the majority of the ex- 
panding  cells  in  the  TCR-ot-/-,  Ipr/lpr  mice  expressed 
TCR-3,/~, it was important to learn which subsets of "y/~ 
T cells were expanding in these mice. We stained LNCs from 
16-wk-old mice for TCR-7/$, CD4, CD8, and B220 and 
analyzed these cells by three-color FACS  |  Representative 
FACS  |  plots  are shown in Fig.  3.  Using  the TCR-qr  + 
gate and quadrant regions shown, we determined the per- 
centage of LNCs in each subset of'y/~ T  cells. Ablation of 
TCR-ct gene expression eliminated the TCR-ot//3 + cell pop- 
ulation and caused an increase in the proportion and absolute 
number of TCK-'y/~ +  cells  in TCR-ct-/-  mice,  as  has 
been reported (29). The phenotype of the TCR-'y/~ + cells 
in these mice was identical to that seen in TCR-c~-intact mice. 
These cells were primarily divided between CD8 § cells and 
DN cells, with a small population expressing CD4 and not 
CDS. Most "y//~  T cells from Fas-intact mice did not express 
B220. In Ipr mice, however, the majority of 3'//~ T cells did 
express B220 but were CD8=. Thus, Fas deficiency skewed 
the 3'/~ T  cell pool toward a B220 + , DN phenotype. 
This skewing of coreceptor and B220 expression of the 
"y/li T cell pool was due to the preferential expansion of the 
DN B220 + subset in TCR-ct-/-, lpr/l  W mice. We multi- 
plied the percentage of lymphocytes in each subset by the 
total cell yield from each mouse to determine the absolute 
number of cells in each subset (Table 3). While all subsets 
of 3,/it T  cells were expanded by Fas deficiency,  the expan- 
sion within the B220 + DN subset was far more dramatic 
than that of any other subpopulation, leading to the skewed 
phenotype. Similar numbers of abnormal TCR-'y/~ + cells 
were observed in TCR-cr-intact Ipr mice. The CD8 + B220- 
3'/~ T  cell subset and the CD4 + B220-  "y/~ T  cell subset 
increased 1.5-fold with Fas deficiency, but the B220-  DN 
"y/it T cells increased 20-fold. The CD4 + B220 § subset also 
increased 20-fold, while the CD8 + B220 + subset expanded 
6-fold. The 300-fold expansion of the DN B220 + 3'/it T cell 
subset, however, obscured the expansion of the other subsets. 
This effect on "y/~ T  cells is similar to that seen in or//3 T 
cells in TCR-ot-intact lpr mice. 
Fas Deficiency Skews the "y/~ T Cell Repertoire Toward Ex- 
pression of Variable Genes Characteristic of Gut-derived y/t~ T 
Cells.  In  TCR-c~-intact  mice,  almost  all  peripheral  LN 
T  ceils express TCR-oJ~, and 3'//~ T  cells are a very small 
population, making these cells difficult to study. This problem 
is further compounded by the massive accumulation of c~//3 
DN T ceils in TCK-cc-intact Ipr mice. The absence of TCK- 
Table 2.  Yield of TCR-fl+Subsets 
Genotype  CD4 §  B220-  CD4 +, B220  +  CD8 +, B220-  CD8 +,  B220  §  DN, B220-  DN, B220 § 
ct+/+,  wt/wt  28.0  -+  8.10  0.161  _  0.024  22.4  +  5.86  0.405  _+  0.042  1.26  -+  0.486  0.349  _+  0.097 
or+~+,  lW/lpr  160.0  _+  110.8  102.0  _+  36.2  102.0  -+  36.2  4.93  _+  1.12  164.0  _+  138.0  1,968  +_  833 
c~-/-,  wt/wt  0.129  -+  0.075  0.048  _+  0.007  0.301  +  0.185  0.062  +  0.042  0.600  +_  0.280  0.399  _+  0.187 
or-~-,  lpr/Ipr  0.189  -+  0.111  0.290  _+  0.160  0.290  +  0.087  2.64  _+  1.28  2.64  +  1.28  4.65  +_  2.13 
Expansion of subsets of TCR-/3  + cells  in Fas-deficient  mice. The yields of cells of each phenotype  are shown in millions per mouse. Values are mean 
_+  SD. Yields x~ere calculated by multiplying the percentage of cells with each phenotype  by the total yield of LNCs. Percentages for CD4 SP 
and CD8 SP cells were determined using the TCR-/3  + cell gate and quadrant regions shown in Fig. 2. Fas deficiency  expands the B220  + subsets 
of TCR-B  + cells in TCR-ct - / -  as well as TCR-c~-intact mice. Data were obtained from the same mice described in Table 1. wt, wild type. 
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Figure 3.  Fas defica'ency  skews  the expanded  3~/8 T cells 
in TCR-~ -/-  mice towards a B220  +, DN phenotype. 
TCR-'~/~5  cells were identified using the histogram gate 
shown to generate  the contour plots. The quadrant regions 
shown were used to calculate the percentage of lympho- 
cytes in each subset. 
a//~ + cells,  especially the vastly expanded ot/B DN T  cells 
of Ipr mice, in TCR-ot -/-  mice allowed us to make a more 
detailed examination  of the effect of Fas deficiency on the 
development of y/8 T cells. To determine the potential source 
of the abnormally expanded 31/8 T cells in Fas-deficient  mice, 
we examined the expression of specific Vy and V8 genes by 
FACS  |  in LNCs of 16-wk-old Fas-intact and Ipr TCR-cr -/- 
mice. Representative FACS  |  plots are shown in Fig. 4. TCR 
V3'4 (also known as V3,2) is normally expressed in periph- 
eral LN "//5  T  cells  (38).  In Fas-intact  TCR-ot-/-  mice 
~20%  of LN 3"/8 T  cells expressed this V region.  In con- 
trast,  ~6%  of the 3,/8  T  cell pool in TCR-ot -/-,  Ipr/Ipr 
mice was stained with anti-V3,4  antibodies.  Dendritic epi- 
dermal T cells characteristically express TCR V3,5 (also known 
as V3,3) in the mouse and are not normally found in the LNs 
of adult  mice (39).  Less than  0.5%  of LN 3,/(5 T  cells  in 
either Fas-intact or Ipr TCR.-ot -/-  mice were stained with 
antibodies to V3"5, indicating that dendritic epidermal T  cells 
did not contribute significantly to the peripheral LN 3,/6 T  cell 
pool in TCK-a-/-  mice. 
Intestinal intraepithdial lymphocytes (ilELs) are a hetero- 
geneous population of mononuclear ceils, primarily T cells, 
which reside in the epithelium  of the gut.  Approximately 
half of ilELs are TCR-3'/~ + ,  and these ceils characteristi- 
cally express TCR V3"7 (also known as V3"5) and TCR V~4 
(37, 40). To determine if cells of this lineage made a significant 
contribution to the expansion of 3'/8 T cells in TCR.-ot -/-, 
Ipr/lpr mice, we stained peripheral LNCs from 16-wk-old mice 
with antibodies to TCR V3'7 and TCR V64 (Fig. 4). In Fas- 
intact  TCR-ot-/-  mice,  •8%  of the 3'/6  T  cells  were 
stained with anti-V3'7.  TCR V~ expression was slightly more 
abundant in these mice:  '~,18%  of 3//8 T  cells.  Expression 
of both these variable regions was much higher in Ipr mice. 
Approximately 15% of 3"/5 T cells expressed V3'7, and >25% 
of 3'/5 T cells expressed TCR V84. These percentages were 
multiplied by the total LNC count to determine the cell yield 
for each subset of 3'/6 T  cells (Fig.  5).  This calculation re- 
vealed a dramatic expansion of 3~/8 T  cells expressing vari- 
able genes characteristic  of ilELs.  Although  Fas deficiency 
caused only a threefold increase in V3'4-expressing cells, from 
238  Fas-deficient  TCR-cr Knock-out Mice Table 3.  Yield of TCR-~,/8 + Subsets 
Genotype  CD4 +,  B220-  CD4 +, B220 +  CD8 +, B220-  CD8 +, B220  +  DN,  B220-  DN, B220 + 
c~+/+, wt/wt  0.044  _+  0.016  0.012  _+  0.002  0.051  _  0.014  0.010  _+  0.004  0.482  _+  0.115  0.025  _+  0.011 
or+~+,  Ipr/Ipr  0.248  _+  0.235  0.392  +  0.224  0.213  _+  0.101  0.061  +  0.010  7.921 _+  5.755  18.38  +  9.44 
c~-/-,  wt/wt  0.211  _+  0.070  0.017  _+  0.001  1.000  _+  0.383  0.033  _+  0.016  1.803 _+  0.923  0.124  +  0.070 
or-~-,  Ipr/Ipr  0.316  _+  0.048  0.303  _+  0.149  1.454 +  0.757  0.198  +  0.105  6.724  _+  1.924  35.50  +  26.90 
Expansion of subsets of TCR-'y/8 + cells in Fas-deficient  mice. The yield of cells with each phenotype  is shown in millions per mouse. Values are 
mean _+ SD. The yield of cells of each phenotype  was calculated  by multiplying the percentage  of cells with that phenotype  by the total cell yield 
from the mouse. Percentages for CD4 SP and CD8 SP cells were determined using the TCR-3,/(5  + cell gate and quadrant regions shown in Fig. 
3. Data shown were obtained from the same mice described in Table 1. wt, wild type. 
an average of 0.6 to 1.7 million per mouse, there was a 12- 
fold increase in Vy7 and V/t4-expressing cells from 0.28 to 
3.4 million and from 0.76 to 9.6 million, respectively. Both 
the V3,4 §  and V3'7/V(54 + subsets  contributed to the ab- 
normal B220 § 3'/~ T  cells observed in TCR-ol -/-,  Ipr/Ipr 
mice (data not shown).  Thus, Fas deficiency causes  an ab- 
normal phenotype in all subsets of 3'//t T cells normally ob- 
served in the LN, but leads  to a preferential expansion of 
those 3'//~ T  cells using variable genes normally associated 
with ilELs. It is not clear if these abnormal LNCs arise from 
cells that were resident in the gut or if they simply arise from 
the same  precursor pool. 
Discussion 
The absence of massive lymphadenopathy in TCR-ot -/-, 
~/~r mice demonstrates that double-positive thymocytes with 
incomplete TCR complexes do not give rise to the c~/3 DN 
T  cells. If unselectable T  cells gave rise to ce/3 DN T  cells 
in Ipr, they should have accumulated faster in TCR-ot-/-, 
Ipr/1pr mice. This potential precursor pool was abundant in 
the thymus of these mice (data not  shown), but TCR-3 + 
DN  cells  were  reduced  ~>100-fold by  the  elimination  of 
TCR-c~ chain expression in lpr mice. Thus, unselected thymo- 
cytes with incomplete TCR complexes can be removed by 
a Fas-independent mechanism. These findings support the 
mounting evidence that points to an essential role for Fas 
in AICD in the periphery but a redundant role, if any at all, 
for Fas in the thymus (7,  22). 
The data presented here clarify the origin of or/3 DN T 
cells in Ipr and identify an important role for Fas in regulating 
peripheral 3'//~ T  cells. The discovery of B220 § 3'//~ T cells 
was quite surprising. This marker has not been reported on 
V//~ cells before, and these cells are not known to be regu- 
lated by AICD. Indeed, little is known about the antigen(s) 
recognized by 3'//t T  cells, nor how their development and 
responses are regulated. The data presented here make it clear, 
however, that Fas-mediated apoptosis plays an important role 
in y/c5 T cell regulation. The identification of this same un- 
usual population in TCR-ot-intact lpr mice shows that this 
phenotype was not an artifact of TCg-ot gene ablation. If 
the parallel between or/3 T cells and 3'//~ T cells holds true, 
these data strongly suggest that 3,//i T  cells are also subject 
to AICD in normal mice. However, the findings reported 
here describe only unmanipulated mice differing in the ex- 
pression of two genes,  so these data do not directly demon- 
strate AICD  in 3'/~5 T  cells. 
There is support for the idea of Fas-mediated AICD regu- 
lation of 3'//~ T  cells in the preferential expansion of cells 
expressing ilEL-associated V3' and V/i genes. Although little 
is known about the antigen(s) recognized by 3'/(5 TCRs, it 
is not difficult to imagine that 3'/~ T  cells in the gut are 
TCRa4- 
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Figure 4.  Fas deficiency  skews 
the 3'/~ T cell  repertoire towards the 
use of variable genes characteristic 
of gut-derived  "y//$  T cells. Repre- 
sentative  histograms  are shown. The 
gates shown were  used to calculate 
the percentage  of  LNCs expressing 
each variable gene region. Figure  5.  Selective  expansion  of  gut-derived  ~//~  T cells  in Fas-deficient 
TCR-c~ -/- mice.  Data are the numbers  of cells expressing  each variable 
region gene, in millions  per mouse. Values shown  are mean  yidds from 
three mice; error bars show SD. 
more often exposed to their cognate antigen(s) than are ~//~ 
T  cells residing in the LNs or the skin. Digestive enzymes 
are constantly reducing dietary and flora-associated  proteins 
to potentially antigenic peptides, and the high concentration 
of these may allow for their presentation by APCs. Further, 
the exposure of the gut to bacteria is the highest exposure 
of any tissue in the body, and many bacteria are known to 
produce superantigens and other agents capable of inducing 
T cell activation. This continual barrage of antigenic stimu- 
lation could lead to the frequent activation of 3'//~ T  cells 
in the gut,  and these multiplying cells may need to be re- 
moved somehow, either to maintain homeostasis or to prevent 
harmful effects  when they traffic beyond the gut.  If Fas- 
mediated AICD fulfills this need, one would expect ilEL- 
derived 3'/~ T cells to accumulate in Ipr mice. This is exactly 
what was  observed,  with more than four times as many 
V3,7/V~4-expressing cells as V3'4-expressing  cells accumu- 
lating in Ipr mice. 
If  this unusual phenotype in "y//~  T cells is a result of  AICD, 
it is probably a general feature of  3'/~ T cells and is not unique 
to ilELs. As stated above, Fas deficiency led to an expansion 
of both V3'4 and V3/7/V/~4-expressing  cells, and both these 
subsets contributed to the B220 + cell pool. We suggest that 
this B220 expression is a hallmark of incipient AICD (7, 22), 
and its presence  in both subsets  of "y//~ T  cells in Ipr mice 
shows the importance of this process in regulating all 3'/~ 
T cells in the periphery. If this is true, the differential expan- 
sion of those cells expressing ilEL-associated V3~ and V~ vari- 
able regions would be due to a difference in exposure to an- 
tigen(s) and in activation, and not to adifference in the process 
of AICD in the two subsets  of cells. 
Further work must be done to demonstrate directly that 
3'//~ T cells are regulated by AICD and that B220 expression 
is its hallmark. If these hypotheses are true, then the B220 + 
3'/~ T  cells of Fas-intact  mice should contain a higher per- 
centage of cells in cycle than the B220-  subset,  as well as 
a significant number of cells with less than a diploid amount 
of DNA, indicating active apoptosis. Direct activation of ~///~ 
T  cells should be able to induce this B220 + phenotype. It 
would be interesting to see ifa disruption of this process were 
observable in any of the diseases of tissues with high numbers 
of 3'/~ T cells, such as the inflammatory bowel diseases. Fi- 
nally, the source of the major population of B220 + ce/3 DN 
T cells in TCR-ce-intact lpr mice has not been resolved.  An 
intriguing possibility,  raised by these findings, is that many 
of these cells may come from the gut. 
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